免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

ExoAtlet-II

K 號:K201473 · 2021-07-16

決定日期2021-07-16
產品代碼PHL
諮詢委員會PM
決定相當於

器材摘要

ExoAtlet-II is the device name listed in this FDA 510(k) record. The listed applicant is Exoatlet Asia Co. , Ltd.. It received FDA 510(k) clearance on 2021-07-16 under 510(k) number K201473. The device is classified under product code PHL. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ExoAtlet-II?

ExoAtlet-II is a medical device that received FDA 510(k) clearance on 2021-07-16. The listed applicant is Exoatlet Asia Co. , Ltd.. The 510(k) number is K201473.

When did ExoAtlet-II receive FDA 510(k) clearance?

ExoAtlet-II received FDA 510(k) clearance on 2021-07-16, under 510(k) number K201473.

Who is the listed applicant for ExoAtlet-II?

The FDA 510(k) record lists Exoatlet Asia Co. , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ExoAtlet-II?

The FDA product code for ExoAtlet-II is PHL.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:PHL)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑